ROSELAND, N.J., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) announced today that management will host a conference call to discuss the Company's financial and operational results for the three months ended June 30, 2016, on Monday, August 15, 2016, at 8:30 AM ET. A press release will be issued prior to market open.
The live webcast of the conference call can be accessed through the Company's website at www.emisphere.com. The call can also be accessed by dialing (877) 303-9483 (United States and Canada) or (760) 666-3584 (international), and entering Conference ID# 59804462.
In addition, an archive of the webcast can be accessed through the same link and an audio replay of the call will be available beginning Monday, August 16, 2016 at 11:30 AM ET through 11:30 AM ET on August 22, 2016, by calling (855) 859-2056
(United States and Canada) or (404) 537-3406 (International), and entering Conference ID# 59804462.
Emisphere Technologies, Inc. ("Emisphere" or the "Company") is a pharmaceutical and drug delivery company. The Company launched its first prescription product, oral Eligen B12™, in the U.S. in March 2015 and we are currently engaged in strategic discussions to optimize its economic value in the U.S. and global markets. Beyond Eligen B12™, the Company utilizes its proprietary Eligen®
Technology to create new oral formulations of therapeutic agents. Emisphere is currently partnered with global pharmaceutical companies for the development of new orally delivered therapeutics. For more information, please visit www.emisphere.com.
Alan L. Rubino, CEO
Alan Gallantar, Acting CFO
Source: Emisphere Technologies, Inc.
News Provided by Acquire Media